MARKET

CRBP

CRBP

Corbus Pharmaceu
NASDAQ
9.38
+0.38
+4.22%
Closed 16:10 07/07 EDT
OPEN
9.09
PREV CLOSE
9.00
HIGH
9.59
LOW
8.99
VOLUME
528.80K
TURNOVER
0
52 WEEK HIGH
20.56
52 WEEK LOW
7.12
MARKET CAP
173.79M
P/E (TTM)
-1.6140
1D
5D
1M
3M
1Y
5Y
1D
Corbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
TipRanks · 1d ago
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio As CMO
NASDAQ · 1d ago
Corbus Pharma names Leonardo Viana Nicacio chief medical officer
PUBT · 2d ago
CORBUS PHARMACEUTICALS APPOINTS LEONARDO VIANA NICACIO, M.D. AS CHIEF MEDICAL OFFICER
Reuters · 2d ago
Press Release: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Dow Jones · 2d ago
Weekly Report: what happened at CRBP last week (0629-0703)?
Weekly Report · 2d ago
Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.5%, Outperforms Peers
Dow Jones · 06/30 20:35
Weekly Report: what happened at CRBP last week (0622-0626)?
Weekly Report · 06/29 09:59
More
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company. The Company has a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The Company’s oncology pipeline comprises two experimental drugs targeting solid tumors: CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFB expressed on cancer cells. CRB-701 is a monoclonal antibody attached to a monomethyl auristatin E (MMAE) cytotoxic payload using a proprietary linker technology. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. CB1 inverse agonism is a clinically validated mechanism to induce weight loss.

Webull offers Corbus Pharmaceuticals Holdings Inc stock information, including NASDAQ: CRBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRBP stock methods without spending real money on the virtual paper trading platform.